Related Experiment Video
Updated: May 21, 2026
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
Published on: October 3, 2010
Extracranial malignant germ cell tumors
Yogesh Kumar Sarin1, Sushmita Nitin Bhatnagar
1Department of Pediatric Surgery, Maulana Azad Medical College, Bahadur Shah Zafar Marg, New Delhi 110002, India. yksarin@hotmail.com
Abstract:
The outstanding clinical trials undertaken for the management of pediatric extracranial malignant germ cell tumors (GCTs) in the developed world in the last three decades has led to excellent longterm outcomes. The scenario in developing country like India is different; results are poor owing to multiple factors such as delayed presentation, misdiagnosis, and early abandonment of the therapy. The authors address here several aspects of this heterogeneous group of malignant tumors in children and adolescents such as the different staging systems, the risk stratification, the guidelines to treatment modalities, the outcome and prognostication.
Insights
Pediatric extracranial malignant germ cell tumors (GCTs) have excellent outcomes in developed nations. However, outcomes are poor in India due to delayed diagnosis and treatment abandonment, necessitating improved management strategies for these childhood cancers.
Area of Science:
- Pediatric Oncology
- Medical Research
- Global Health Disparities
Background:
- Pediatric extracranial malignant germ cell tumors (GCTs) management has advanced significantly in developed countries.
- Outcomes in developing nations, particularly India, lag due to delayed presentation, misdiagnosis, and therapy abandonment.
- Significant disparities exist in the management and outcomes of pediatric GCTs globally.
Purpose of the Study:
- To analyze the challenges and outcomes of pediatric extracranial malignant germ cell tumors (GCTs) in India.
- To review current staging systems, risk stratification, and treatment guidelines for pediatric GCTs.
- To provide insights into prognostication and improve management strategies in resource-limited settings.
Main Methods:
- Review of clinical trial data and management guidelines for pediatric extracranial malignant GCTs.
- Analysis of factors contributing to poor outcomes in developing countries like India.
- Discussion of staging, risk stratification, treatment modalities, and prognostication.
Main Results:
- Developed nations report excellent long-term outcomes for pediatric GCTs.
- India faces challenges including delayed diagnosis, misdiagnosis, and early treatment cessation.
- Heterogeneity in presentation and management impacts outcomes in pediatric GCTs.
Conclusions:
- Addressing delayed presentation and treatment abandonment is crucial for improving pediatric GCT outcomes in India.
- Standardized staging, risk stratification, and evidence-based treatment protocols are needed.
- Further research and collaborative efforts are essential to bridge the gap in pediatric GCT care globally.
